Drug regulator to appeal Wales Korea case

Published: 2013-09-26 06:59:00

Updated: 2013-09-26 06:59:00

The Ministry of Food and Drug Safety (MFDS) said Tuesday it will file an appeal immediately with the Higher Court against the Suwon District Court’s ruling in favor of Wales Korea to lift the sales ban of some medicines produced by the company.

The MFDS's decision came days after the court par...

Fees

- Email service daily and homepage access.

$300 per month. ($3,240 per year)
5 Email holders per each company.
Anual contract base.

Latest News

Which are outstanding tetravalent vaccines even for the young?

Disease treated the most with clinical trial drugs is respiratory disorder like lung cancer

Who will be the next Pharmaceutical Safety Bureau Director?

Celltrion completes clinical trials for Remsima SC for European approval

Sales listed pharmas made in the first half of the year

TOP

BACK